Medibiofarma
PrivateLast Round
Grant
Sep 9, 2025
Total Funding Raised
$1.18M
Company Overview
Medibiofarma operates in Healthcare & Life Sciences and is based in Spain. Its latest recorded funding round was a Grant round in September 2025.
Medibiofarma is a biotechnology company that discovers and develops small molecule drugs for the treatment of cancer, neurological disorders, and fibrotic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Medibiofarma Comparables
Compare Medibiofarma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Oncostellae | 86% | |
| Palobiofarma S.L. | 84% | |
| AtG Therapeutics | 81% |
For institutional investors. Book with your work email.
Medibiofarma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 9, 2025 | ||||
| VC Round | Apr 3, 2024 | ||||
| Grant | Mar 3, 2023 | ||||
| Debt | Mar 15, 2022 | ||||
| VC Round | Mar 15, 2022 | ||||
Grant | Mar 15, 2022 |
For institutional investors. Book with your work email.
Medibiofarma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Inveready | VC Round |
| Empresa Nacional de Innovación | Debt |
| Center for Technological Development and Innovation | Grant |
| Crohn's & Colitis Foundation | Grant |
| Fitalent | VC Round |
| Sodena | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 16, 2026
Monthly visitors increased 277% MoM to 1.4K.
- Jan 8, 2026
Monthly visitors grew 203% MoM, from 417 to 1.3K.
For institutional investors. Book with your work email.
Medibiofarma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Medibiofarma's valuation, stock price, and market status.
Is Medibiofarma a public or private company?
Medibiofarma is a private company.
What is the current stock price of Medibiofarma?
Medibiofarma is a private company, so its shares have no public market price. Caplight tracks Medibiofarma's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Medibiofarma worth (valuation)?
Valuation information for Medibiofarma is not publicly available.
Can I buy Medibiofarma stock?
Medibiofarma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Medibiofarma's last funding round?
Medibiofarma's most recent funding round was Grant on September 9, 2025.
Who are the main investors in Medibiofarma?
Key investors in Medibiofarma include Inveready, Empresa Nacional de Innovación, Center for Technological Development and Innovation, Crohn's & Colitis Foundation, Fitalent.
Will Medibiofarma IPO soon?
No public IPO plans have been announced for Medibiofarma.
How can I track Medibiofarma secondary market activity?
Caplight tracks bids, offers, and trades in Medibiofarma's shares on secondary markets.